Skip to main content

Table 1 Demographic and clinical characteristics, by partner type

From: Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: Results of analyses from a multicenter randomized trial

Characteristic

HIV-1 infected partner

HIV-1-uninfected partner

 

(N = 3295)

(N = 3295)

 

Men

Women

Men

Women

 

(n = 1073)

(n = 2222)

(n = 2222)

(n = 1073)

Age, median (IQR)

37 (32,45)

30 (25, 35)

35 (30, 42)

31 (25, 38)

Informal settlement¶

404 (38%)

859 (39%)

869 (39%)

390 (39%)

Married to study partner

866 (81%)

1627 (73%)

1636 (74%)

864 (81%)

Cohabiting with study partner

1002 (93%)

1970 (89%)

1983 (89%)

1000 (93%)

>8 years of education completed

512 (48%)

901 (41%)

1157 (52%)

401 (37%)

Any income

638 (59%)

546 (25%)

1331 (60%)

280 (26%)

CD4, median, cells/mm3 (IQR)

  

-

-

Enrollment

426 (334, 571)

481 (354, 664)

  

Final visit

394 (276, 544)

437 (312, 617)

  

HIV-1 plasma RNA, median, log10 copies/mL (IQR)

  

-

-

Enrollment

4.2 (3.5, 4.8)

3.8 (3.0, 4.4)

  

Final visit

4.4 (3.6, 5.0)

4.0 (3.2, 4.7)

  

Ever on ART over follow up

112 (10%)

178 (8%)

-

-

Highest WHO stage of HIV-1

  

-

-

< 3

806 (75%)

1720 (77%)

  

3

243 (23%)

436 (20%)

  

4

24 (2%)

66 (3%)

  
  1. ¶Informal Settlement, as defined by study participants.